Online inquiry

IVTScrip™ mRNA-Human AREG, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK21961MR)

This product GTTS-WK21961MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the AREG protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001657.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 374
UniProt ID P15514
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AREG, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK21961MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK15450MR IVTScrip™ mRNA-Human AMH, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA AMH
GTTS-WK3306MR IVTScrip™ mRNA-Human FGF10, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA FGF10
GTTS-WK26761MR IVTScrip™ mRNA-Human AREG, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AREG
GTTS-WK17354MR IVTScrip™ mRNA-Human anti-Mullerian hormone, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA anti-Mullerian hormone
GTTS-WK11576MR IVTScrip™ mRNA-Human ACVR1, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ACVR1
GTTS-WK14276MR IVTScrip™ mRNA-Human ACVR1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ACVR1
GTTS-WK0906MR IVTScrip™ mRNA-Human FGF10, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA FGF10
GTTS-WK19980MR IVTScrip™ mRNA-Human ANGPT2, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ANGPT2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →